agilon health, inc. (NYSE:AGL – Free Report) – Stock analysts at William Blair raised their Q3 2025 earnings per share (EPS) estimates for shares of agilon health in a note issued to investors on Tuesday, May 6th. William Blair analyst R. Daniels now forecasts that the company will post earnings per share of ($0.08) for the quarter, up from their prior forecast of ($0.09). The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. William Blair also issued estimates for agilon health’s Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.23) EPS, Q3 2026 earnings at ($0.07) EPS and FY2026 earnings at ($0.13) EPS.
A number of other analysts have also recently weighed in on the company. TD Cowen increased their price target on agilon health from $3.50 to $6.00 and gave the stock a “hold” rating in a research report on Tuesday, April 15th. Stifel Nicolaus increased their target price on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday, February 26th. Barclays raised their target price on agilon health from $2.00 to $3.00 and gave the company an “underweight” rating in a research note on Thursday. Citigroup upgraded shares of agilon health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $3.25 to $5.00 in a research report on Friday, April 25th. Finally, Robert W. Baird cut their price objective on shares of agilon health from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 15th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $4.89.
agilon health Trading Down 10.9 %
NYSE AGL opened at $2.87 on Friday. The firm has a market capitalization of $1.19 billion, a PE ratio of -3.05 and a beta of 0.38. agilon health has a one year low of $1.50 and a one year high of $7.73. The company has a 50-day simple moving average of $4.27 and a 200-day simple moving average of $3.19. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.
agilon health (NYSE:AGL – Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same period last year, the business posted ($0.02) earnings per share. The firm’s revenue for the quarter was down 4.5% on a year-over-year basis.
Institutional Investors Weigh In On agilon health
A number of institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its holdings in agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after acquiring an additional 1,083,492 shares during the period. Inspire Investing LLC grew its stake in shares of agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after purchasing an additional 112,241 shares during the last quarter. Cerity Partners LLC bought a new stake in shares of agilon health in the 4th quarter worth approximately $34,000. Geode Capital Management LLC lifted its stake in agilon health by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after purchasing an additional 35,207 shares during the last quarter. Finally, MetLife Investment Management LLC boosted its holdings in agilon health by 4.0% during the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock worth $332,000 after buying an additional 6,762 shares in the last quarter.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than agilon health
- About the Markup Calculator
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
- What is the S&P/TSX Index?
- Here’s The Reason Goldman Sachs Is Bullish On MercadoLibre Stock
- What is MarketRank™? How to Use it
- Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.